₹100 per equity share with a face value of ₹10. The issue is entirely a fresh issue of 19.64 lakh shares worth ₹19.64 crore. The net proceeds from the issue are to be utilised towards funding the capital expenditure towards the installation of plant and machinery for existing laboratories and for expansion of laboratories, repayment of unsecured loans to the promoter, working capital requirements of the company, and general corporate purposes, according to the company's DRHP report.
The minimum lot size for an application is 1200 shares. The minimum amount of investment required by retail investors is ₹1,20,000. The minimum lot size investment for HNI is 2 lots (2,400 shares) amounting to ₹2,40,000.
Qualitek Labs IPO has reserved not more than 50 percent of the shares in the public issue for retail investors. Oneview Corporate Advisors Private Limited is the book-running lead manager of the Qualitek Labs IPO, while Skyline Financial Services Private Ltd is the registrar for the issue. The market maker for Qualitek Labs IPO is Nikunj Stock Brokers.
Qualitek Labs IPO basis for allotment of shares will be finalised on January 23, and the company will initiate refunds on January 24. The shares will be credited to the demat accounts of allottees on the same day following the refund. Qualitek Labs shares are likely to be listed on the BSE SME Platform on January 25.
Read more on livemint.com